tirzepatide in hfpef Effects of on the Clinical Trajectory of Patients With Heart Failure, Preserved Ejection Fraction, and Obesity Real-world outcomes for GLP‑1 therapies
Pay in 4 interest-free payments of $5.35 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Live Spec
Real world outcomes for GLP1 therapies in HFpEF and T2DM published in @JAMA_current: In >97k U.S. patients, semaglutide & tirzepatide each reduced HF hospitalization all cause mortality by >40% vs sitagliptin confirming STEPHFpEF DM Tirzepatide cuts heart failure risk in HFpEF patients Tirzepatide Helps in HFpEF Across Spectrum of Obesity Severity ICYMI: Eli Lilly's tirzepatide showed a 38% reduction in heart failure outcomes and improved symptoms in adults with #HFpEF and #obesity in the phase 3 SUMMIT trial. https: t.co W4My4YF2Ks Therapy for HFpEF: A step forward brings new hope for people with obesity and diabetes: Med
Store: www.jokijarvenlomat.fi · Domain: www.jokijarvenlomat.fi




























